Who
Dan Dearborn
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, TuHURA Biosciences.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Oct 2024
- Last trade
- 6 Jan 2026
- Last filed
- 8 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Jan 2026filed 8 Jan 2026 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —273,696 at $0.00 | filing |
| 6 Jan 2026filed 8 Jan 2026 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —273,696 at $0.00 | filing |
| 12 Dec 2025filed 17 Dec 2025 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,531,367 at $0.00 | filing |
| 12 Nov 2024filed 14 Nov 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —489,848 at $0.00 | filing |
| 18 Oct 2024filed 22 Oct 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,991 at $0.00 | filing |
| 18 Oct 2024filed 22 Oct 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —68,438 at $0.00 | filing |
| 18 Oct 2024filed 22 Oct 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —232,570 at $0.00 | filing |
| 18 Oct 2024filed 22 Oct 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,744 at $0.00 | filing |
| 18 Oct 2024filed 22 Oct 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,658 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.